Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06397937
Other study ID # U01NS135533
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 1, 2024
Est. completion date January 31, 2029

Study information

Verified date April 2024
Source Columbia University
Contact Olajide Williams, MD
Phone (212) 305-1710
Email ow11@cumc.columbia.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Primary Goal: To test the hypothesis that among AA and Hispanic stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3) epigenetic allostatic load biomarkers (exploratory outcome) such as DNA methylation (DNAm) and telomere length, at 6 months and 1-year post-stroke, compared with usual care (UC).


Description:

Structural Racism and Discrimination (SRD) produces adverse Social Determinants of Health (SDOH), which have been shown increase stroke risk in a dose dependent manner. The SDOH-Homecare Intervention Focus Team (SHIFT) trial is a Phase 3, randomized, blinded outcome trial that tests the hypothesis that a homecare intervention shortly after discharge from an acute stroke unit by a team comprising a community health worker (CHW), a community social worker (CSW) and a community nurse (CN) can improve health outcomes among Black and Hispanic stroke patients compared with UC.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 250
Est. completion date January 31, 2029
Est. primary completion date January 31, 2029
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: 1. Ischemic stroke (arterial subtypes) or primary intracerebral hemorrhage (excluding diagnosis of probable CAA) 2. African American/Black or Hispanic race-ethnicity. 3. Age 18-75 years old. 4. Have at least 3 SDOH barriers from within the 5 SDOH domains (Social and Community, Education, Economic, neighborhood/environment, Health Care). 5. Have a discharge plan to 1) home with or without home services, or 2) acute rehabilitation with plan to return home after. 6. Pre-stroke Modified Rankin Scale score of =3 7. Residence in New York City.. 8. English or Spanish speaking. 9. Can provide informed consent and engage in the initial assessment prior to stroke discharge. 10. Lives in a household with a telephone, and has a caregiver (family member or Home Health Aide) if not fully independent on discharge. If the patient requires a family member to assist with activities of daily living or decision-making, the family member must state a willingness to be present at home visits where their assistance is needed. Exclusion Criteria: 1. Discharge disposition to a long term care facility. 2. Diagnosis of dementia or other neurological neurological diagnosis that affects cognition. 3. Diagnosis of active major depression. 4. Aphasia severe enough to preclude initial examination. 5. Impaired level of consciousness at initial cognitive assessment. 6. Subarachnoid hemorrhage. 7. Diagnosis of probable cerebral amyloid angiopathy by Boston criteria. 8. Life expectancy less than 1 year.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
SHIFT team intervention
The SHIFT team, comprising a community health worker (CHW), community social worker (CHW), and community nurse (CN) will visit the participant starting within 72 hours of hospital discharge and provide social service referrals related to food insecurity, housing, immigration, and employment, and assist with medical appointment preparation (CHW), deliver individualized counseling focused on coping skills, reducing caregiver strain, and the psychological distress associated with experiences of racism and SDOH (CSW), and address health literacy and review of treatment goals and medications (CN).

Locations

Country Name City State
United States Columbia University Medical Center New York New York

Sponsors (2)

Lead Sponsor Collaborator
Columbia University National Institute of Neurological Disorders and Stroke (NINDS)

Country where clinical trial is conducted

United States, 

References & Publications (2)

Harris J, Boehme A, Chan L, Moats H, Dugue R, Izeogu C, Pavol MA, Naqvi IA, Williams O, Marshall RS. Allostatic load predicts racial disparities in intracerebral hemorrhage cognitive outcomes. Sci Rep. 2022 Oct 3;12(1):16556. doi: 10.1038/s41598-022-20987-x. — View Citation

Mallaiah J, Williams O, Allegrante JP. Development and Validation of a Stroke Literacy Assessment Test for Community Health Workers. Health Educ Behav. 2024 Apr 22:10901981241245050. doi: 10.1177/10901981241245050. Online ahead of print. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Medication Adherence medication adherence 6 months and 1 year
Other 30-day readmission rate incidence of readmission to the hospital within 30 days of discharge 30 days post discharge
Other Epigenetic biomarkers of stress DNA methylation, telomere length baseline, 6 months and 1 year
Primary Stroke Impact Scale v3.0 a validated measure of disability and health-related quality of life after stroke baseline, 6 months and 1 year
Secondary Blood pressure change in blood pressure from baseline baseline, 6 months and 1 year
Secondary cognition Montreal Cognitive Assessment battery (MoCA) baseline, 6 months and 1 year
Secondary Stroke Specific Quality of Life (SSQOL) validated quality of life measure 6 months and 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Recruiting NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Active, not recruiting NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Recruiting NCT05621980 - Finger Movement Training After Stroke N/A